Eversheds Bianchini, with a team headed by Marco Franzini and also with the associate Nicola Zito, has acted as legal advisor of Health Holding Company S.r.l., Mandarin Capital Partners SCA SICAR and Dedalus Group for the reorganization of the shareholding structure of the Dedalus Group, the reinvestment of Health Holding Company Srl and Mandarin Capital Partners SCA SICAR and the investment of Hutton Collins.

The operation led to the buy-out of the exiting minority shareholders and the raising of about EUR 25 million fresh money to the finance expansion, internationalization and consolidation plans of Dedalus Group, now wholly owned by Dedalus Holding S.p.A., with shareholders Health Holding Company S.r.l. (over 50%), Mandarin Capital Partners SCA SICAR (almost 36%) and HC Leo SA the Luxco of Hutton Collins (14%).

The Dedalus Group - established in Florence, roughly EUR 70 million revenues and EUR 17 million EBITDA - is today the largest Italian company in the healthcare information systems business, operating worldwide in 12 countries. Dedalus consolidated more than 30 companies in Italy and internationally in the recent years, as part of its plans to become the new Italian healthcare ICT reference for excellence. Thanks to the support of Mandarin Capital Partners SCA SICAR, shareholder of the company since 2010, Dedalus has been able to successfully penetrate the Chinese market where it is today established with over 150 people.

 “It was a structured and important transaction for our clients and also for the private equity market, not only mid-market in Italy - said Marco Franzini, head of the Italian private equity and banking practice - and we are honored to have assisted a group like Dedalus and its controlling shareholders for the raising of equity and debt capital for the expansion and internationalization of the group.”